Glesatinib(MGCD265)
99%
- Product Code: 100650
CAS:
875337-44-3
| Molecular Weight: | 517.6 g./mol | Molecular Formula: | C₂₆H₂₀FN₅O₂S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD17779287 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Glesatinib is primarily used in the field of oncology as a targeted therapy for certain types of cancer. It functions as a dual inhibitor of MET and AXL, which are receptor tyrosine kinases involved in cancer cell growth, survival, and metastasis. This makes it particularly effective in treating cancers where these pathways are dysregulated, such as non-small cell lung cancer (NSCLC). By inhibiting these receptors, Glesatinib helps to slow down or stop the progression of cancer, offering a more tailored treatment option for patients with specific genetic mutations or alterations. Its application is often explored in clinical trials to assess its efficacy and safety in various cancer types, potentially providing a new therapeutic avenue for patients who may not respond well to conventional treatments.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿4,590.00 |
+
-
|
Glesatinib(MGCD265)
Glesatinib is primarily used in the field of oncology as a targeted therapy for certain types of cancer. It functions as a dual inhibitor of MET and AXL, which are receptor tyrosine kinases involved in cancer cell growth, survival, and metastasis. This makes it particularly effective in treating cancers where these pathways are dysregulated, such as non-small cell lung cancer (NSCLC). By inhibiting these receptors, Glesatinib helps to slow down or stop the progression of cancer, offering a more tailored treatment option for patients with specific genetic mutations or alterations. Its application is often explored in clinical trials to assess its efficacy and safety in various cancer types, potentially providing a new therapeutic avenue for patients who may not respond well to conventional treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :